Synthetic peptides for diagnostic use

Veterinary Quarterly

Volumn 19, Issue 3, 1997, Pages 114-118

  Meloen, R H ^b   Langedijk, J P M ^b   Langeveld, J P M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGENICITY; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CENTRAL NERVOUS SYSTEM INFECTION; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRION DISEASE; QUALITY CONTROL; VIRUS INFECTION;

BOVINAE; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 85007815932     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1997.9694755     Document Type: Review

References (53)

1. Ball JM, Rushlow KE, Issel CJ, and Montelaro RC. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol 1992; 66 (2): 732–42.
2. Bray AM, Maeji NJ, and Geysen HM. The simultaneous multiple production of solution phase peptides; assessment of the Geysen method of simultaneous peptide synthesis. Tetrahedron Letters 1990; 31: 5811.
3. Brookes SM, Pandolfino YA, Mitchell T.J. Venables PJ, Shattles WG, Clark DA, Entwistle A, and Maini RN. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J Rheumatol 1992; 31 (11): 735–42.
4. Carballido JM, Carballido-Perrig N, Kagi M, et al. T-cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J Immunol 1993; 150: 3582.
5. Cello J, and Svennerholm B. Detection of enterovirus-specific total and polymeric IgA antibodies in serum using a synthetic peptide or heated virion antigen in ELISA. J Med Virol 1994; 44 (4): 422–7.
6. Coursaget P, Depril N, Buisson Y, Molinie C, and Roue R. Hepatitis type E in a French population: detection of anti HEV by a synthetic peptide-based enzyme-linked immunosorbent assay. Res Virol 1994; 145 (1): 51–7.
7. Fierro GM del, Bundesen P, Martin S, Jones S, Beetson S, and Robinson WF. Evaluation of an autologous red cell agglutination test, VetRED FIV, for the presence of FIV antibody in cats. Vet Immunol Immunopathol 1995; 46 (1-2): 93–101.
8. Devine PL, McGuckin MA, Birrell GW, Whitehead RH, Sachdev GP, Shield P, and Ward BG. Monoclonal antibodies reacting with the MUC2 mucin core protein. Br J Cancer 1993; 67 (6): 1182–8.
9. Eden W van Noordzij A, Hensen EJ, et al. A modified PEPSCAN method for rapid identification and characterization of T-cell epitopes in protein antigens. In: Vaccines 89, Cold Spring Harbor Laboratory, NY, USA, 1989 p 33.
10. Fabrizi F, Raffaele L, Guarnori I, Bacchin G, Marai P, Erba G, and Locatelli F. Comparison of second-generation screening and confirmatory assays with recombinant antigens and synthetic peptides against antibodies to hepatitis C virus: a study in renal patients. Nephron 1995; 69: 444–8.
11. Geluk A, Meijgaarden KE van, Janson AAM, et al. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specefic competitor peptides. J Immunol 1992; 149: 2864.
12. Geysen HM, Meloen RH, and Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 1984; 81: 3998.
13. Geysen HM, Barteling SJ, and Meloen RH. Small peptides induce antibodies with a sequence and structural requirements for binding antigen comparable to antibodies raised against the native protein. Proc Natl Acad Sci USA 1985; 82: 178.
14. Geysen HM, Rodda SJ, Mason TJ, et al. Strategies for epitope analysis using peptide synthesis. J Immunol Meth 1987; 102: 259.
15. Geysen HM. Molecular technology: Peptide epitope mapping and the pin technology. South East Asian J Trop Med Public Health 1990; 21: 523.
16. Goudsmit J, Debouck C, Meloen RH, et al. HIV type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci USA 1988; 85: 4478.
17. Grunsven WM van, Spaan W.I, and Middeldorp JM. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis 1994; 170 (1): 13–9.
18. Guttinger M, Romagnoli P, Vandel L, et al. HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Internatl Immunol 1991; 3: 899.
19. Helftenbein E, Kunz H, and Hartter P. Laboratory diagnosis of parvovirus B 19 infection: comparison of ten commercial IgG- and IgM-antibody tests. Immun Infekt 1994; 22 (5): 181–6.
20. Hines JJ, Danho W, and Elkon KB. Detection and quantification of human anti-Sm antibodies using Synthetic peptide and recombinant SmB antigens. Arthritis-Rheum 1991; 34 (5): 572–9.
21. Hirschberg L, Holme T, and Krook A. Human antibody response to the major adhesin of Mycoplasma pneumoniae: increase in titers against synthetic peptides in patients with pneumonia. APMIS 1991; 99 (6): 515–20.
22. Jones IIM, Schachter 1, and Stephens RS. Evaluation of the humoral immune response in trachoma to Chlamydia traelunnatis major outer membrane proteins by sequence-defined immunoassay. J Infect Dis 1992; 166 (4): 915–9.
23. Kast WM, Offringa R, Peters PJ, et al. Eradication of Adenovirus Elinduced tumors by E1A specific cytotoxic T lymphocytes. Cell 1989; 59: 603.
24. Kast WM, Roux L, Curren J. Blom I ILI et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with an unbound synthetic peptide. Proc Natl Acad Sci USA 1991; 88: 2283.
25. Keulen LJM van, Schreuder BEC, Meloen RH, Poclen-van den Berg M, Mooij-I larkes G, Vromans MEW, and Langeveld JPM. Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapic. Vet Pathol 1995; 32: 99–308.
26. Keulen LIM van, Schreuder BEC, Meloen RH, Mooij-I larkes G, Vromans MEW, and Langeveld JPM. Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapic. J Clinical Microbiol 1996; 34: 1228–31.
27. Khudyakov YuE, Khudyakova NS, Jue DL, Wells TW, Padhya N, and Fields I IA. Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus. J Gen Virol 1994; 75 (3): 641–6.
28. Langedijk JPM, Middel WGJ, Schaaper WMM, Meloen RI I, Kramps JA, Brandenburg Al I, and Oirschot JI van. Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G. J 1mm Meth 1996; 193: 157–66.
29. Langedijk JPM, Schaaper WMM, Meloen RII, and Oirschot JT van. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J Gen Virol 1996; 77: 1249–57.
30. Langeveld JPM, Fraquhar CF, Pocchiari M, Birkett C, Bostock C, and Meloen R H. Antigenic sites of bovine prion protein. In: ‘Transmissible Spongi form Encephalopathies’, Proceedings of a Consultation on BSE with the Scientific Veterinary Committee of the Commission of the European Communities held in Brussels, 14-15 September 1993.
31. Licrop M-JC van, Maanen K van, Melocn RH, et al. Proliferative lymphocyte responses to Foot-and-Mouth disease virus and three FMDV-peptides after vaccination or immunization with these peptides in cattle. Immunology 1992; 75: 406.
32. Maeji NJ, Bray AM, Valerio RM, et al. Systematic screening for bioactive peptides. Peptide Res 1991; 4: 142.
33. Maury CP. Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 1991; 64 (3): 400–4.
34. Meloen RH, Amerongen A van, Hage-van Noort M, et al. The use of peptides to reconstruct conformational determinants. A brief review. Annales de Biologic Clinique 1991; 49: 231.
35. Meloen RH, Puijk WC, Langeveld JPM, Langedijk JPM, Amerongen A van, and Schaaper WMM. PEPSCAN to determine T and B cell epitopes. In: Immunological Recognition of Peptides in Medicine and Biology. Zegers N, Boersma W and Claassen E. (eds.) CRC Press, Inc, Florida. 1995: 15–31.
36. Park ILI, Byun SM, Ha YJ, Ahn JS, and Moon HM. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides. J Immunoassay 1995; 16: 167–81.
37. Qi Z, Cui D, Pan W, Yu C, Song Y, Cui H, and Arima T. Synthesis and application of hepatitis E virus peptides to diagnosis. J Virol Methods 1995; 55 (1): 55–66.
38. Ricchiuti V, briand JP, Meyer O, Isenberg DA, Pruijn G, and Muller S. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol 1994; 95 (3): 397–407.
39. Rimmelzwaan GF, Poelen MCM, Meloen RH, et al. Delineation of canine parvovirus T cell epitopes with peripheral blood mononuclear cells and T cell clones from immunized dogs. J Gen Virol 1990; 71: 2321–9.
40. Rosa C, Osborne S, Garetto F, Griva S, Rivella A, Calabresi G, Guaschino R, and Bonelli F. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis. J Virol Methods 1995; 55 (2): 219–32.
41. Samuelson A, Glimaker M, Skoog E, Cello J, and Forsgrcn M. Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 1993; 40 (4): 271–7.
42. Schreuder BEC, Keulen LJM van, Vromans MEW, Langeveld JPM, and Smits MA. Preclinical test for prion diseases. Nature 1996; 381: 563.
43. Shah K, Davis C, Wilson J, and Parekh B. Chimeric synthetic peptides as antigens for detection of antibodies to IIIV-1 and HIV-2. East Afr Med I 1996; 73 (1): 63–6.
44. Siiss G, Matile II, Meloen RH, et al. Identifying polymorphic regions of the p190 protein from different Plasmodium falciparum strains by using specific T cells. Parasite Immunol 1993; 15: 127.
45. Tosswill JH, McAlpine L, and Mortimer PP. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens. J Med Virol 1993; 40 (I): 83–5.
46. Tuaillon N, Andre C, Briand JP, Penner E, and Muller SA. Lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. J Immunol 1992; 148 (2): 445–50.
47. Tyndall MW, Gomez AM, Maitha G, Ndinya-Achola JO, MacLean I, Plummer FA, and Rosenthal KL. Early detection of HIV-1 in men from Kenya using a synthetic peptide and a p24 antigen enzyme-linked immunosorbent assay. AIDS 1994; 8 (11): 1625–6.
48. Vordermeier HM, Harris DP, Friscia G, et al. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. EurJ Immunol 1992; 22: 2631.
49. Wauben MHM, Zee R vd, Joosten I et al. Peptide variant of an arthritis relaed T-cell cpitopc induces T cells that recognise this epitope as a synthetic peptide but not in its naturally processed form. J Immunol 1993; 150: 5722.
50. Wilson KM, Gerometta M, Rylatt DB, Bundesen PG, McPhee DA, Hillyard CJ, and Kemp BE. Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate. J Immunol Methods 1991; 138 (1): 111–9.
51. Yoshida CF, Rouzere CD, Nogucira RM, Lampe E, Travassos da Rosa MA, Vanderborght BO, and Schatzmayr HG. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus. Braz I Med Biol Res 1992; 25 (11): 1131–5.
52. Zee R vd, Eden W van, Meloen RH, et al. Efficient mapping and characterization of a T-cell epitope by the simultaneous synthesis of multiple peptides. Eur J Immunol 1989; 19: 43.
53. Zhang ZX, Yun ZB, Chen M, Sonnerborg A, and Sallberg M. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. J Med Virol 1995; 45: 50–5.